Skip to main content
MRNA
NASDAQ Life Sciences

Moderna's mRNA-1403 Fails Early-Success Bar in Phase 3 Interim Look

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$237
Mkt Cap
$96.399B
52W Low
$22.28
52W High
$261
52W Position info
964% above low
Off High info
9.2% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MRNA has more than doubled off its 52-week low of $22.28.

Summary

Moderna said the Phase 3 interim analysis of mRNA-1403 did not meet the statistical criteria for early success, and it will not start an additional cohort this season. That is a setback for one of the pipeline programs the company has been counting on beyond its COVID franchise. It lands the same morning as the Q3 report showing 38 cents of EPS and a swing to profit, so the market has to weigh a clinical miss against an improving bottom line. The company gave no timeline for the next data readout on this program.

At the time of this announcement, MRNA was trading at $237.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $96.4B. The 52-week trading range was $22.28 to $261.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

MRNA - Latest Insights

MRNA
Nov 12, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $247.31
Real-time Price: $199.30 info
Change: -$48.01 (-19%) info
Market Cap: $78.901B info
MRNA
Nov 07, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $256.92
Real-time Price: $199.30 info
Change: -$57.62 (-22%) info
Market Cap: $78.901B info
MRNA
Nov 06, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $255.50
Real-time Price: $199.30 info
Change: -$56.20 (-22%) info
Market Cap: $78.901B info
MRNA
Nov 06, 2026, 1:11 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $258.37
Real-time Price: $199.30 info
Change: -$59.07 (-23%) info
Market Cap: $78.901B info
MRNA
Nov 06, 2026, 7:07 AM EST
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $265.00
Real-time Price: $199.30 info
Change: -$65.70 (-25%) info
Market Cap: $78.901B info